| Matrix metalloproteinases: regulators of the tumor microenvironment K Kessenbrock, V Plaks, Z Werb Cell 141 (1), 52-67, 2010 | 5727 | 2010 |
| The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? V Plaks, N Kong, Z Werb Cell stem cell 16 (3), 225-238, 2015 | 1559 | 2015 |
| Circulating tumor cells V Plaks, CD Koopman, Z Werb Science 341 (6151), 1186-1188, 2013 | 774 | 2013 |
| Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance ES Nakasone, HA Askautrud, T Kees, JH Park, V Plaks, AJ Ewald, M Fein, ... Cancer cell 21 (4), 488-503, 2012 | 532 | 2012 |
| Uterine DCs are crucial for decidua formation during embryo implantation in mice V Plaks, T Birnberg, T Berkutzki, S Sela, A BenYashar, V Kalchenko, ... The Journal of clinical investigation 118 (12), 3954-3965, 2008 | 467 | 2008 |
| Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial CA Jacobson, JC Chavez, AR Sehgal, BM William, J Munoz, G Salles, ... The lancet oncology 23 (1), 91-103, 2022 | 423 | 2022 |
| MRI detection of transcriptional regulation of gene expression in transgenic mice B Cohen, K Ziv, V Plaks, T Israely, V Kalchenko, A Harmelin, LE Benjamin, ... Nature medicine 13 (4), 498-503, 2007 | 250 | 2007 |
| Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis V Plaks, A Brenot, DA Lawson, JR Linnemann, EC Van Kappel, KC Wong, ... Cell reports 3 (1), 70-78, 2013 | 249 | 2013 |
| A role for Notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia NM Hunkapiller, M Gasperowicz, M Kapidzic, V Plaks, E Maltepe, ... Development 138 (14), 2987-2998, 2011 | 214 | 2011 |
| WST11, A Novel Water‐soluble Bacteriochlorophyll Derivative; Cellular Uptake, Pharmacokinetics, Biodistribution and Vascular‐targeted Photodynamic Activity Using Melanoma … O Mazor, A Brandis, V Plaks, E Neumark, V Rosenbach‐Belkin, ... Photochemistry and photobiology 81 (2), 342-351, 2005 | 209 | 2005 |
| Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction V Plaks, J Rinkenberger, J Dai, M Flannery, M Sund, K Kanasaki, W Ni, ... Proceedings of the National Academy of Sciences 110 (27), 11109-11114, 2013 | 198 | 2013 |
| Gap junctions in the ovary: expression, localization and function E Gershon, V Plaks, N Dekel Molecular and cellular endocrinology 282 (1-2), 18-25, 2008 | 176 | 2008 |
| Primary analysis of Zuma-5: a phase 2 study of axicabtagene ciloleucel (Axi-Cel) in patients with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) C Jacobson, JC Chavez, AR Sehgal, BM William, J Munoz, G Salles, ... Blood 136, 40-41, 2020 | 144 | 2020 |
| CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel V Plaks, JM Rossi, J Chou, L Wang, S Poddar, G Han, Z Wang, SQ Kuang, ... Blood, The Journal of the American Society of Hematology 138 (12), 1081-1085, 2021 | 115 | 2021 |
| Adaptive immune regulation of mammary postnatal organogenesis V Plaks, B Boldajipour, JR Linnemann, NH Nguyen, K Kersten, Y Wolf, ... Developmental cell 34 (5), 493-504, 2015 | 106 | 2015 |
| Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma N Scholler, R Perbost, FL Locke, MD Jain, S Turcan, C Danan, EC Chang, ... Nature medicine 28 (9), 1872-1882, 2022 | 100 | 2022 |
| MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy M Owyong, J Chou, RJE van den Bijgaart, N Kong, G Efe, C Maynard, ... Life science alliance 2 (6), 2019 | 95 | 2019 |
| CD19-loss with preservation of other B cell lineage features in patients with large B cell lymphoma who relapsed post-axi-cel SS Neelapu, JM Rossi, CA Jacobson, FL Locke, DB Miklos, PM Reagan, ... Blood 134, 203, 2019 | 74 | 2019 |
| Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma MS Topp, T van Meerten, R Houot, MC Minnema, K Bouabdallah, ... British journal of haematology 195 (3), 388-398, 2021 | 68 | 2021 |
| Interim analysis of ZUMA-5: A phase II study of axicabtagene ciloleucel (axi-cel) in patients (pts) with relapsed/refractory indolent non-Hodgkin lymphoma (R/R iNHL). CA Jacobson, JC Chavez, AR Sehgal, BM William, J Munoz, GA Salles, ... Journal of Clinical Oncology 38 (15_suppl), 8008-8008, 2020 | 67 | 2020 |
